FindMyKOL
Clinical trialNCT04553627UnknownInterventional

Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis

NCT04553627 is an interventional trial sponsored by Riverchase Dermatology. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Subcutaneous Fat. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 15 Jul 2020 and a primary completion date of 30 Apr 2021.

SponsorRiverchase DermatologyEnrollment10Subcutaneous Fat
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04553627
FieldValue
Registry IDNCT04553627
StatusUnknown
Study typeInterventional trial
Lead sponsorRiverchase Dermatology
Enrollment10
Registered sites1
Countries1
ConditionsSubcutaneous Fat
Start15 Jul 2020
Primary completion30 Apr 2021
Study completion30 May 2021
Last update posted19 Oct 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and efficacy of cryolipolysis of the medial infragluteal fold to create the appearance of a gluteal lift.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Florida, United States1 site
  • Riverchase Dermatology

    Miami

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFlorida: 1 siteFL1District of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04553627

Each answer restates registry values shown on this page.

What is NCT04553627?

NCT04553627 is an interventional trial sponsored by Riverchase Dermatology. It studies Subcutaneous Fat.

Who leads NCT04553627?

The registry names Leyda R Bowes, MD (principal investigator, Riverchase Dermatology) as the overall official.

Where does NCT04553627 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04553627 expected to complete?

The registry lists a primary completion date of 30 Apr 2021 and a study completion date of 30 May 2021. The sponsor last updated the record on 19 Oct 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.